Skip to search.
 FTSE 100 Up 0.09%

Sarepta Therapeutics, Inc. (SRPT)

-NasdaqGS
16.81 Down 0.41(2.38%) 19:06 - Nasdaq Real Time Price
Prev Close:17.22
Open:16.94
Bid:16.89 x 200
Ask:16.94 x 900
1y Target Est:17.92
Beta:1.21751
Earnings Date:5 May - 9 May (Est.)
Day's Range:15.83 - 18.01
52wk Range:8.00 - 41.97
Volume:8,678,114
Avg Vol (3m):5,358,810
Market Cap:767.65m
P/E (ttm):N/A
EPS (ttm):-5.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for SRPT at this time.

Comparison

Symbol% ChgMkt Cap
SRPTDown 2.38%767.65m
GSKUp 0.09%102.57b
ALNYUp 2.63%5.03b
ISISDown 0.48%6.91b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):627.59
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-4.56
Quarterly EPS Est (Mar-16) :-1.28
Mean Recommendation*:2.9
PEG Ratio (5 yr expected):18.90

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback